JO SANDBU CLINICAL RESEARCH AS
Keywords
physicalchemicalanalytical testingmaterialsproductsacoustic testingvibration testingcompositionpurityfood hygieneveterinary controlperformance testingtype approvalcertificationclassification
Organization
- CEO
- JS
Jo Sandbu1948
- Chairman of the board
- JS
Jo Sandbu1948
- Years since formation
- 20 years
- since Dec 3, 2005
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 1,000
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Total operating income 2023
- 163,473
- NOK
- Annual total result 2023
- -142,027
- NOK
- Total equity 2023
- 1,296,380
- NOK
Last update: Aug 29, 2024
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
JS 1948 | Managing Director/CEO | 100 % directly |
Board
| Name | Role | Shares |
|---|---|---|
JS 1948 | Chairman | 100 % directly |
MS | Alternate Member | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
JS 1948 | Managing Director/CEO, Chairman | 100 % directly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
JS 1948 | Ordinary shares | 1,000 | 100 % |
Shares owned by the JO SANDBU CLINICAL RESEARCH AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| NO0010582521 | 593 | < 0.01 % |
Last update: May 24, 2024
Financials
in NOK
Summary
| Year | 2023 | 2022 | 2021 |
|---|---|---|---|
Total operating income | 163,473 | 151,323 | 473,707 |
Annual Total Result | -142,027 | -264,902 | 117,538 |
Total assets | 1,581,246 | 1,594,391 | 1,770,480 |
Total liabilities | 284,867 | 155,985 | 67,170 |
Total equity | 1,296,380 | 1,438,407 | 1,703,309 |
P&L
| Year | 2023 | 2022 | 2021 |
|---|---|---|---|
Total operating income | 163,473 | 151,323 | 473,707 |
Total operating costs | 306,399 | 416,453 | 351,886 |
Operating result | -142,926 | -265,130 | 121,821 |
Financial income/costs | 899 | 228 | -4,283 |
Profit before tax | -142,027 | -264,902 | 117,538 |
Total tax & extraordinary income/cost | 0 | 0 | 0 |
Annual Total Result | -142,027 | -264,902 | 117,538 |
Balance overview
| Year | 2023 | 2022 | 2021 |
|---|---|---|---|
Total fixed assets | 6,341 | 10,433 | 14,526 |
Total current assets | 1,574,905 | 1,583,958 | 1,755,954 |
Total assets | 1,581,246 | 1,594,391 | 1,770,480 |
Short term debt | 284,867 | 155,985 | 67,170 |
Long term debt | 0 | 0 | 0 |
Total liabilities | 284,867 | 155,985 | 67,170 |
Contributed capital | 100,000 | 100,000 | 100,000 |
Retained earnings | 1,196,380 | 1,338,407 | 1,603,309 |
Total equity | 1,296,380 | 1,438,407 | 1,703,309 |
Total equity and liabilities | 1,581,247 | 1,594,392 | 1,770,479 |
Classification
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
71
Activity
Architectural and engineering activities; technical testing and analysis
71.2
Main industrial group
Technical testing and analysis
71.20
Industrial group
Technical testing and analysis
71.200
Industrial group
Technical testing and analysis